Incannex Healthcare Inc. (IXHL): who owns it and who trades it
As of Nov 16, 2026, no open-market insider purchases or sales of IXHL were reported in the last 12 months. 2 of the 50 famous funds we follow held it at their last quarter end.
Latest filing Nov 16, 2026. From Form 4, 13F and Schedule 13D/G filings.
At a glance
Insider trades
No IXHL insider reported an open-market purchase or sale in the last 12 months.
What this data shows, and what it doesn't
- Shows: open-market purchases and sales by officers, directors and 10%+ owners, reported on Form 4 within two business days of the trade.
- Leaves out: stock awards, option exercises, shares withheld for tax and gifts. These are not trades at a market price chosen by the insider.
- "plan" marks a sale made under a Rule 10b5-1 plan, a schedule set up in advance.
- Fund holders come from 13F reports, a snapshot at quarter end filed up to 45 days later.
- Filings are self-reported and can be amended. Each trade links to its original filing. Methodology
IXHL short interest
Low short interest. 2.9% of IXHL shares are sold short: about 1 share in 35. Over the last 12 reports the number of shares short went down 55%.
As a rough guide, under 5% is low, 5–10% is moderate, 10–20% is high and over 20% is very high.
As of Oct 30, 2026, 358,009 IXHL shares were sold short, 2.9% of the shares outstanding, down 13.0% from the report before. At the average daily volume of 62,849 shares, buying them all back would take about 5.7 trading days (days to cover).
Shares short, % of all shares
Days to cover
Every report
| Settlement date | Shares short | % of shares | Change | Avg daily volume | Days to cover |
|---|---|---|---|---|---|
| Oct 30, 2026 | 358,009 | 2.85% | -13% | 62,849 | 5.7 |
| Oct 15, 2026 | 411,587 | 3.28% | -10% | 62,505 | 6.6 |
| Sep 30, 2026 | 456,097 | 3.64% | -36% | 117,516 | 3.9 |
| Sep 15, 2026 | 716,308 | 5.99% | -3% | 71,532 | 10.0 |
| Aug 31, 2026 | 736,022 | 6.15% | -9% | 87,134 | 8.4 |
| Aug 14, 2026 | 812,491 | 6.79% | -8% | 95,499 | 8.5 |
| Jul 31, 2026 | 884,664 | 7.39% | -12% | 92,968 | 9.5 |
| Jul 15, 2026 | 1.00M | 8.40% | +97% | 275,500 | 3.6 |
| Jun 30, 2026 | 509,079 | 4.25% | -34% | 272,224 | 1.9 |
| Jun 15, 2026 | 769,519 | 6.43% | -8% | 357,737 | 2.1 |
| May 29, 2026 | 834,495 | 6.97% | +4% | 193,751 | 4.3 |
| May 15, 2026 | 801,478 | 6.70% | -19% | 303,763 | 2.6 |
Short sellers borrow shares and sell them, hoping to buy them back for less. A high number means many such bets are open. It does not say where the price will go. Source: FINRA equity short interest, reported by brokers twice a month (positions on the 15th and the last business day) and published about 7 business days later. % of shares uses the share count on the company's latest SEC filing. What short interest means · Most shorted stocks
Incannex Healthcare company events
Incannex Healthcare filed 24 reports on Form 8-K in the last 12 months, 1 of them about an important change (listing). The latest was on Sep 9, 2026.
- Sep 9, 2026AnnouncementShared information with investors. Filing
- Aug 25, 2026AnnouncementShared information with investors. Filing
- Aug 11, 2026AnnouncementShared information with investors. Filing
- Jul 23, 2026AnnouncementShared information with investors. Filing
- Jun 25, 2026AnnouncementShared information with investors. Filing
- Jun 10, 2026AnnouncementShared information with investors. Filing
- Jun 9, 2026AnnouncementShared information with investors. Filing
- May 14, 2026AnnouncementShared information with investors. Filing
- May 12, 2026AnnouncementShared information with investors. Filing
- Apr 22, 2026AnnouncementShared information with investors. Filing
- Mar 27, 2026AnnouncementShared information with investors. Filing
- Mar 25, 2026AnnouncementShared information with investors. Filing
- Mar 18, 2026AnnouncementShared information with investors. Filing
- Mar 17, 2026ListingIncannex Healthcare Inc. received a letter from the Listing Qualifications Department of The Nasdaq Stock Market LLC notifying the Company that the bid price deficiency under Nasdaq Listing Rule 5550(a)(2), which the Company previously reported on in its Current Reports on Form 8-K filed on April… Filing
- Mar 12, 2026AgreementIncannex Healthcare Inc., a Delaware corporation, entered into a Securities Purchase Agreement with certain institutional investors, pursuant to which the Company agreed to issue and sell, in a registered direct offering by the Company directly to the Investors, (i) an aggregate of 1,997,285 shares… Filing
- Mar 12, 2026AnnouncementThe Company issued a press release announcing its enhanced Phase 2 dose-optimisation study. Filing
- Feb 25, 2026SharesChanged the rights of its shareholders. Filing
- Jan 29, 2026AnnouncementIncannex Healthcare Inc. Announces Additional Appointments to Clinical Advisory Board. Filing
- Jan 22, 2026AnnouncementIncannex Healthcare Inc. Announces Formation of Clinical Advisory Board for PSX-001 Program. Filing
- Jan 16, 2026VoteReported shareholder vote results. Filing
- Jan 15, 2026AnnouncementIncannex Healthcare Inc. Wins Research and Development Award for Obstructive Sleep Apnea Program in the 2025 Clinical Trials Arena Excellence Awards. Filing
- Jan 14, 2026AnnouncementIncannex Healthcare Inc. Delivers Transformational 2025 Progress and Outlines Well-Funded Outlook for 2026. Filing
- Dec 18, 2025AnnouncementIncannex Healthcare Inc. announced at the 2025 annual meeting of stockholders that there were not present or represented by proxy a sufficient number of shares of our common stock to constitute a quorum, primarily due to Proposal No. 2, relating to the ratification of the appointment of its… Filing
- Dec 3, 2025AnnouncementIncannex Healthcare Inc. issued a press release announcing that the Company was granted U.S. Food and Drug Administration Fast Track designation for IHL-42X in obstructive sleep apnea. Filing
From 8-K reports, which a company must file within 4 business days of an important event. Where a report is about a change such as a new CEO, the sentence is the first one from the report itself, shortened. Each row links to the original filing. Company events this week
Incannex Healthcare financials
Famous investors that hold IXHL
2 of the 50 well-known investors we track reported holding IXHL in their latest 13F filing. The largest position is Israel Englander's, worth $209K.
| Fund | Quarter | Shares | Value | Of portfolio | Change |
|---|---|---|---|---|---|
| Israel Englander · Millennium Management | Q3 2026 | 64,503 | $209K | 0.0% | -32% |
| Ken Griffin · Citadel Advisors | Q3 2026 | 53,635 | $174K | 0.0% | +418% |
From 13F reports: a snapshot at quarter end, filed up to 45 days later. Change compares with the quarter before.
Questions about Incannex Healthcare Inc. (IXHL) stock
Are IXHL insiders buying or selling?
No IXHL insider reported an open-market purchase or sale on Form 4 in the last 12 months. Share awards, option exercises and gifts are not counted.
What is the short interest in IXHL?
As of Oct 30, 2026, 358,009 IXHL shares were sold short, 2.9% of the shares outstanding, down 13.0% from the report before. At the average daily volume of 62,849 shares, buying them all back would take about 5.7 trading days (days to cover). See the history.
Which famous investors hold IXHL?
2 of the 50 well-known investors we track reported IXHL in their latest 13F filing, including Israel Englander, Ken Griffin. The largest position is worth $209K. See all holders.
Source: SEC Form 4 (insiders, filed within 2 business days), 13F (funds, up to 45 days after quarter end) and Schedule 13D/13G filings. Only open-market purchases (code P) and sales (code S) are shown. Data only, not investment advice. How we collect it.